Please login to the form below
vaccines
This page shows the latest vaccines news and features for those working in and with pharma, biotech and healthcare.
MSD taps Austria’s Themis to bolster vaccine pipeline
There isn’t much detail on the project, which involves the development of multiple vaccine candidates against an undisclosed disease target. ... The vaccine delivers the antigens directly to macrophages and dendritic cells, which Themis says are the
Latest news
-
Pfizer goes big on gene therapy with $500m facility spend
The new manufacturing plant will be located at Pfizer’s facility in Sanford, North Carolina, where it already produces vaccines including its blockbuster childhood immunisation Prevnar 13 and several experimental shots,
-
UK no longer measles-free as vaccination rates fall dramatically
vaccine messages and using the NHS website to address misleading claims about vaccines. ... There has been increasing global scepticism around the safety and efficacy of vaccines, with WHO now naming ‘vaccine hesitancy’ as one of the top ten
-
Potential cure for Ebola following trial success
Although there is an Ebola vaccine developed by Merck which has proven 100% efficacy, until now an effective treatment for Ebola once a patient has already been infected has not been
-
Boehringer Ingelheim forms ‘virtual research’ alliance with MD Anderson
Boehringer has increased its focus on oncology recently, with its recent acquisition of Swiss cancer vaccines company AMAL therapeutics boosting Boehringer’s pipeline with five preclinical cancer vaccines.
-
Bayer takes control of BlueRock stem cell joint venture
In April, Leaps by Bayer made an undisclosed investment in US-based biotech Khloris Biosciences, which specialises in using iPSCs as prophylactic and therapeutic vaccines, using them as a vehicle to
More from news
Approximately 98 fully matching, plus 1,008 partially matching documents found.
Latest Intelligence
-
Biotech profile: Tom Evans, CEO, Vaccitech.
The second development pathway is as an adjunct for seasonal vaccines to boost efficacy to levels higher than those achieved by the seasonal vaccine alone. ... You have a broad pipeline of candidates, including therapeutic vaccines, such as your vaccine
-
Crossing the digital divide between big pharma and real-world patients
Specifically in the healthcare space, a recent Royal Society for Public Health report highlighted that two in five parents are exposed to negative messages about vaccines on social media, and found
-
The UK’s new medicines pricing deal – opportunities and risks for pharma
There are also exemptions in what gets considered, including exceptional central procurements, vaccines, small company sales and low value sales.
-
Combining therapies and combining research
Of course, other strategies also play their part: improved antibiotic stewardship, good infection control, publicity about AMR, more effective vaccines, less use of antibiotics in agriculture, fast diagnostic testing, more professionals
-
The UK’s new five-year pricing agreement
This means that people across the UK should see better and faster access to the most effective new medicines and vaccines.”.
More from intelligence
Approximately 5 fully matching, plus 83 partially matching documents found.
Latest appointments
-
Bone Therapeutics strengthens board with new chairman
He has also been a member of the corporate executive team for GlaxoSmithKline and chief executive officer of GSK Biologicals (now GSK Vaccines).
-
McCann Health appoints Daniel Carucci as global medical director
Dr Carucci has over 25 years of experience in large-scale innovation programs, vaccine development, organisational leadership, and global public health, during which time he served as VP for global health
-
Professor Carole Longson moves from NICE to the ABPI
and the role our members play in developing new innovative medicines and vaccines.
-
Lilly bolsters its oncology team
Furthermore, she has been on the forefront of research in oncology vaccines, immuno-oncology and biosimilars, giving her the unique expertise that will be pivotal in helping us continue to develop
-
Relay Therapeutics appoints Sarah O’Brien as VP of HR
Prior to Sobi, O’Brien spent seven years working at Novartis for its vaccines arm and then with the Novartis Institute for Biomedical Research (NIBR), where she worked closely with the
More from appointments
Approximately 5 fully matching, plus 61 partially matching documents found.
Latest from PMHub
-
The impossible launch
th. century, those who discovered insulin, antibiotics, IVF, polio vaccine, the contraceptive pill to name a few, have made incredible positive changes to people’s lives across the planet.
-
Cello Health launches ‘Cello Health GmbH’ with new Berlin office and appointment of two regional directors to lead the Business Insights and Analytics division in Germany.
Heike Tombrink brings to Cello Health Insight more than 20 years of expertise as a strategic market research consultant, having worked internationally for Pharma (RX, OTC, Vaccines), Medical Supplies and MedTech
-
Mergers and acquisitions: agents for change
From the $63 billion AbbVie-Allergan merger currently in play, to the BMS-Celgene merger earlier this year, division sales such as the transfer of Novartis vaccines unit to GSK, or
-
Fake News is Bad for your Health
Trust in vaccines fell as a result of emotional contagion, triggered by the 1998 publication of Andrew Wakefield's paper in the Lancet linking the MMR vaccine with autism and bowel ... Openness and transparency build credibility. Education on vaccines
-
Why eating people is wrong (and other medical discoveries)
He reasoned that this was because they had been exposed to the closely-related cowpox, which he then used as the basis of a smallpox vaccine. ... The word vaccine comes from vacca, the Latin name for 'cow').
More from PMHub
Approximately 4 fully matching, plus 27 partially matching documents found.
Featured jobs
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
-
Account Director – UK Office
-
Excellent salary and benefits
- Account Director, Healthcare Communications
-
Salary TBC
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
Subscribe to our email news alerts
- Finch Therapeutics bags $53m for microbiome therapies
- MSD taps Austria’s Themis to bolster vaccine pipeline
- Early ‘no’ for GW Pharma’s epilepsy drug, but NICE vows to collaborate
- GSK preps filings for BCMA-targeting multiple myeloma drug
- Behaviour change – is there something missing?
- NICE’s long-serving chief exec Sir Andrew Dillon to step down
PMHub
Market Access Transformation
Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...
Latest intelligence
- Empowered patients: shaking the foundations of healthcare
- Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
- A uniquely English genomic medicine service
- The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
- Blended Intelligence
- Data is the most valued commodity of the modern world. For P&P it's all about the application....
Quick links
Infographics
